United Therapeutics Rockets 10% On Growing Enthusiasm For Its Top Drug

BREAKING: Futures Rise On Trump Comments, EarningsUnited Therapeutics (UTHR) on Wednesday reported adjusted earnings of $7.16 per share on $799.5 million in third-quarter sales.In response, United Therapeutics stock slipped a fraction to 412.50. Still, shares have a strong IBD Digital Composite Rating of 96, putting them in the top 4% of all stocks in terms of fundamental and technical measures.Analysts polled by FactSet expected United Therapeutics to earn $7.32 per share and report $813 million in sales. ...